A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.
The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.
Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.
A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic.
An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.
A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.
A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.
An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.
Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
An autosomal recessive lipid storage disorder due to mutation of the gene CYP27A1 encoding a CHOLESTANETRIOL 26-MONOOXYGENASE. It is characterized by large deposits of CHOLESTEROL and CHOLESTANOL in various tissues resulting in xanthomatous swelling of tendons, early CATARACT, and progressive neurological symptoms.
Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed.
The glycine conjugate of CHOLIC ACID. It acts as a detergent to solubilize fats for absorption and is itself absorbed.
A condition marked by the development of widespread xanthomas, yellow tumor-like structures filled with lipid deposits. Xanthomas can be found in a variety of tissues including the SKIN; TENDONS; joints of KNEES and ELBOWS. Xanthomatosis is associated with disturbance of LIPID METABOLISM and formation of FOAM CELLS.
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
CHOLESTENES with one or more double bonds and substituted by any number of keto groups.
Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.
A liver microsomal cytochrome P450 enzyme that catalyzes the 12-alpha-hydroxylation of a broad spectrum of sterols in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP8B1gene, converts 7-alpha-hydroxy-4-cholesten-3-one to 7-alpha-12-alpha-dihydroxy-4-cholesten-3-one and is required in the synthesis of BILE ACIDS from cholesterol.
The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
Unsaturated derivatives of cholane with methyl groups at C-10 and C-13 and a branched five-carbon chain at C-17. They must have at least one double bond in the ring system.
Enzymes of the oxidoreductase class that catalyze the dehydrogenation of hydroxysteroids. (From Enzyme Nomenclature, 1992) EC 1.1.-.
A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic.
Cytochrome P-450 monooxygenases (MIXED FUNCTION OXYGENASES) that are important in steroid biosynthesis and metabolism.
Recycling through liver by excretion in bile, reabsorption from intestines (INTESTINAL REABSORPTION) into portal circulation, passage back into liver, and re-excretion in bile.
A cholesterol derivative found in human feces, gallstones, eggs, and other biological matter.
A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS.
A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic.
A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.
The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic.
A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.
'Cholanes' are not recognized as a medical term; however, it is possible that the term is being referred to as "bile acids," which are steroid acids that play an essential role in lipid digestion and absorption in the small intestine.
A genus of gram-positive, rod-shaped bacteria found in cavities of man and animals, animal and plant products, infections of soft tissue, and soil. Some species may be pathogenic. No endospores are produced. The genus Eubacterium should not be confused with EUBACTERIA, one of the three domains of life.
Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
A semisynthetic bile acid made from cholic acid. It is used as a cholagogue, hydrocholeretic, diuretic, and as a diagnostic aid.
An NAPH-dependent cytochrome P450 enzyme that catalyzes the oxidation of the side chain of sterol intermediates such as the 27-hydroxylation of 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol.
Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
Radiography of the gallbladder after ingestion of a contrast medium.
A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion.
Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix.
Intracellular receptors that can be found in the cytoplasm or in the nucleus. They bind to extracellular signaling molecules that migrate through or are transported across the CELL MEMBRANE. Many members of this class of receptors occur in the cytoplasm and are transported to the CELL NUCLEUS upon ligand-binding where they signal via DNA-binding and transcription regulation. Also included in this category are receptors found on INTRACELLULAR MEMBRANES that act via mechanisms similar to CELL SURFACE RECEPTORS.
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.
A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids.
Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Cholesterol which is substituted by a hydroxy group in any position.
A genus of the family Muridae having three species. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research.
Surgical removal of the GALLBLADDER.
Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.
The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough.
A family of sterols commonly found in plants and plant oils. Alpha-, beta-, and gamma-isomers have been characterized.
An antibacterial agent that has been used in veterinary practice for treating swine dysentery and enteritis and for promoting growth. However, its use has been prohibited in the UK following reports of carcinogenicity and mutagenicity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p125)
Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.
Errors in the metabolism of LIPIDS resulting from inborn genetic MUTATIONS that are heritable.
Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.
The rate dynamics in chemical or physical systems.
A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.
Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed)
A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
The composition, conformation, and properties of atoms and molecules, and their reaction and interaction processes.
Cholesterol present in food, especially in animal products.
Conditions with excess LIPIDS in the blood.
Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-hydroxy-3-methylglutaryl-coenzyme A to yield MEVALONIC ACID.
The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.
Tritium is an isotope of hydrogen (specifically, hydrogen-3) that contains one proton and two neutrons in its nucleus, making it radioactive with a half-life of about 12.3 years, and is used in various applications including nuclear research, illumination, and dating techniques due to its low energy beta decay.
Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms.

Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis. (1/469)

Samples of serum, bile, and urine were collected simultaneously from patients with cholestasis of varying aetiology and from patients with cirrhosis; their bile acid composition was determined by gas/liquid chromatography and mass spectrometry. In cholestasis, the patterns in all three body fluids differed consistently and strikingly. In serum, cholic acid was the major bile acid and most bile acids (greater than 93%) were unsulphated, whereas, in urine, chenodeoxycholic was the major bile acid, and the majority of bile acids (greater than 60%) were sulphated. Secondary bile acids were virtually absent in bile, serum, and urine. The total amount of bile acids excreted for 24 hours correlated highly with the concentration of serum bile acids; in patients with complete obstruction, urinary excretion averaged 71-6 mg/24 h. In cirrhotic patients, serum bile acids were less raised, and chenodeoxycholic acid was the predominant acid. In healthy controls, serum bile acids were consistently richer in chenodeoxycholic acid than biliary bile acids, and no bile acids were present in urine. No unusual monohydroxy bile acids were present in patients with primary biliary cirrhosis, but, in several patients, there was a considerable amount of hyocholic acid present in the urinary bile acids. The analyses of individual bile acids in serum and urine did not appear to provide helpful information in the differential diagnosis of cholestasis. Thus, in cholestasis, conjugation of chenodeoxycholic acid with sulphate becomes a major biochemical pathway, urine becomes a major route of bile acid excretion, and abnormal bile acids are formed.  (+info)

Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. (2/469)

Intestinal carcinogenesis involves the successive accumulation of multiple genetic defects until cellular transformation to an invasive phenotype occurs. This process is modulated by many epigenetic factors. Unconjugated bile acids are tumor promoters whose presence in intestinal tissues is regulated by dietary factors. We studied the role of the unconjugated bile acid, chenodeoxycholate, in an animal model of familial adenomatous polyposis. Mice susceptible to intestinal tumors as a result of a germline mutation in Apc (Min/+ mice) were given a 10 week dietary treatment with 0.5% chenodeoxycholate. Following this, the mice were examined to determine tumor number, enterocyte proliferation, apoptosis and beta-catenin expression. Intestinal tissue prostaglandin E2 (PGE2) levels were also assessed. Administration of chenodeoxycholate in the diet increased duodenal tumor number in Min/+ mice. Promotion of duodenal tumor formation was accompanied by increased beta-catenin expression in duodenal cells, as well as increased PGE2 in duodenal tissue. These data suggest that unconjugated bile acids contribute to periampullary tumor formation in the setting of an Apc mutation.  (+info)

PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp. (3/469)

As enteric pathogens, Salmonella spp. are resistant to the actions of bile. Salmonella typhimurium and Salmonella typhi strains were examined to better define the bile resistance phenotype. The MICs of bile for wild-type S. typhimurium and S. typhi were 18 and 12%, respectively, and pretreatment of log-phase S. typhimurium with 15% bile dramatically increased bile resistance. Mutant strains of S. typhimurium and S. typhi lacking the virulence regulator PhoP-PhoQ were killed at significantly lower bile concentrations than wild-type strains, while strains with constitutively active PhoP were able to survive prolonged incubation with bile at concentrations of >60%. PhoP-PhoQ was shown to mediate resistance specifically to the bile components deoxycholate and conjugated forms of chenodeoxycholate, and the protective effect was not generalized to other membrane-active agents. Growth of both S. typhimurium and S. typhi in bile and in deoxycholate resulted in the induction or repression of a number of proteins, many of which appeared identical to PhoP-PhoQ-activated or -repressed products. The PhoP-PhoQ regulon was not induced by bile, nor did any of the 21 PhoP-activated or -repressed genes tested play a role in bile resistance. However, of the PhoP-activated or -repressed genes tested, two (prgC and prgH) were transcriptionally repressed by bile in the medium independent of PhoP-PhoQ. These data suggest that salmonellae can sense and respond to bile to increase resistance and that this response likely includes proteins that are members of the PhoP regulon. These bile- and PhoP-PhoQ-regulated products may play an important role in the survival of Salmonella spp. in the intestine or gallbladder.  (+info)

The effect of bile salts and calcium on isolated rat liver mitochondria. (4/469)

Intact mitochondria were incubated with and without calcium in solutions of chenodeoxycholate, ursodeoxycholate, or their conjugates. Glutamate dehydrogenase, protein and phospholipid release were measured. Alterations in membrane and organelle structure were investigated by electron paramagnetic resonance spectroscopy. Chenodeoxycholate enhanced enzyme liberation, solubilized protein and phospholipid, and increased protein spin label mobility and the polarity of the hydrophobic membrane interior, whereas ursodeoxycholate and its conjugates did not damage mitochondria. Preincubation with ursodeoxycholate or its conjugate tauroursodeoxycholate for 20 min partially prevented damage by chenodeoxycholate. Extended preincubation even with 1 mM ursodeoxycholate could no longer prevent structural damage. Calcium (from 0.01 mM upward) augmented the damaging effect of chenodeoxycholate (0.15-0.5 mM). The combined action of 0.01 mM calcium and 0.15 mM chenodeoxycholate was reversed by ursodeoxycholate only, not by its conjugates tauroursodeoxycholate and glycoursodeoxycholate. In conclusion, ursodeoxycholate partially prevents chenodeoxycholate-induced glutamate dehydrogenase release from liver cell mitochondria by membrane stabilization. This holds for shorter times and at concentrations below 0.5 mM only, indicating that the different constitution of protein-rich mitochondrial membranes does not allow optimal stabilization such as has been seen in phospholipid- and cholesterol-rich hepatocyte cell membranes, investigated previously.  (+info)

Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. (5/469)

We investigated whether curcumin, a chemopreventive agent, inhibited chenodeoxycholate (CD)- or phorbol ester (PMA)-mediated induction of cyclooxygenase-2 (COX-2) in several gastrointestinal cell lines (SK-GT-4, SCC450, IEC-18 and HCA-7). Treatment with curcumin suppressed CD- and PMA-mediated induction of COX-2 protein and synthesis of prostaglandin E2. Curcumin also suppressed the induction of COX-2 mRNA by CD and PMA. Nuclear run-offs revealed increased rates of COX-2 transcription after treatment with CD or PMA and these effects were inhibited by curcumin. Treatment with CD or PMA increased binding of AP-1 to DNA. This effect was also blocked by curcumin. In addition to the above effects on gene expression, we found that curcumin directly inhibited the activity of COX-2. These data provide new insights into the anticancer properties of curcumin.  (+info)

Antilithiasic effect of beta-cyclodextrin in LPN hamster: comparison with cholestyramine. (6/469)

Beta-Cyclodextrin (BCD), a cyclic oligosaccharide that binds cholesterol and bile acids in vitro, has been previously shown to be an effective plasma cholesterol lowering agent in hamsters and domestic pigs. This study examined the effects of BCD as compared with cholestyramine on cholesterol and bile acid metabolism in the LPN hamster model model for cholesterol gallstones. The incidence of cholesterol gallstones was 65% in LPN hamsters fed the lithogenic diet, but decreased linearly with increasing amounts of BCD in the diet to be nil at a dose of 10% BCD. In gallbladder bile, cholesterol, phospholipid and chenodeoxycholate concentrations, hydrophobic and lithogenic indices were all significantly decreased by 10% BCD. Increases in bile acid synthesis (+110%), sterol 27-hydroxylase activity (+106%), and biliary cholate secretion (+140%) were also observed, whereas the biliary secretion of chenodeoxycholate decreased (-43%). The fecal output of chenodeoxycholate and cholate (plus derivatives) was increased by +147 and +64%, respectively, suggesting that BCD reduced the chenodeoxycholate intestinal absorption preferentially. Dietary cholestyramine decreased biliary bile acid concentration and secretion, but dramatically increased the fecal excretion of chenodeoxycholate and cholate plus their derivatives (+328 and +1940%, respectively). In contrast to BCD, the resin increased the lithogenic index in bile, induced black gallstones in 34% of hamsters, and stimulated markedly the activities of HMG-CoA reductase (+670%), sterol 27-hydroxylase (+310%), and cholesterol 7alpha-hydroxylase (+390%). Thus, beta-cyclodextrin (BCD) prevented cholesterol gallstone formation by decreasing specifically the reabsorption of chenodeoxycholate, stimulating its biosynthesis and favoring its fecal elimination. BCD had a milder effect on lipid metabolism than cholestyramine and does not predispose animals to black gallstones as cholestyramine does in this animal model.  (+info)

Identification of a nuclear receptor for bile acids. (7/469)

Bile acids are essential for the solubilization and transport of dietary lipids and are the major products of cholesterol catabolism. Results presented here show that bile acids are physiological ligands for the farnesoid X receptor (FXR), an orphan nuclear receptor. When bound to bile acids, FXR repressed transcription of the gene encoding cholesterol 7alpha-hydroxylase, which is the rate-limiting enzyme in bile acid synthesis, and activated the gene encoding intestinal bile acid-binding protein, which is a candidate bile acid transporter. These results demonstrate a mechanism by which bile acids transcriptionally regulate their biosynthesis and enterohepatic transport.  (+info)

Bile acids: natural ligands for an orphan nuclear receptor. (8/469)

Bile acids regulate the transcription of genes that control cholesterol homeostasis through molecular mechanisms that are poorly understood. Physiological concentrations of free and conjugated chenodeoxycholic acid, lithocholic acid, and deoxycholic acid activated the farnesoid X receptor (FXR; NR1H4), an orphan nuclear receptor. As ligands, these bile acids and their conjugates modulated interaction of FXR with a peptide derived from steroid receptor coactivator 1. These results provide evidence for a nuclear bile acid signaling pathway that may regulate cholesterol homeostasis.  (+info)

Chenodeoxycholic acid (CDCA) is a bile acid that is naturally produced in the human body. It is formed in the liver from cholesterol and is then conjugated with glycine or taurine to become a primary bile acid. CDCA is stored in the gallbladder and released into the small intestine during digestion, where it helps to emulsify fats and facilitate their absorption.

CDCA also has important regulatory functions in the body, including acting as a signaling molecule that binds to specific receptors in the liver, intestines, and other tissues. It plays a role in glucose and lipid metabolism, inflammation, and cell growth and differentiation.

In addition to its natural functions, CDCA is also used as a medication for the treatment of certain medical conditions. For example, it is used to dissolve gallstones that are composed of cholesterol, and it is also used to treat a rare genetic disorder called cerebrotendinous xanthomatosis (CTX), which is characterized by the accumulation of CDCA and other bile acids in various tissues.

It's important to note that while CDCA has therapeutic uses, it can also have adverse effects if taken in high doses or for extended periods of time. Therefore, it should only be used under the supervision of a healthcare professional.

Cholic acids are a type of bile acid, which are naturally occurring steroid acids that play a crucial role in the digestion and absorption of fats and fat-soluble vitamins in the body. Cholic acid is the primary bile acid synthesized in the liver from cholesterol. It is then conjugated with glycine or taurine to form conjugated cholic acids, which are stored in the gallbladder and released into the small intestine during digestion to aid in fat emulsification and absorption.

Cholic acid and its derivatives have also been studied for their potential therapeutic benefits in various medical conditions, including liver diseases, gallstones, and bacterial infections. However, more research is needed to fully understand the mechanisms of action and potential side effects of cholic acids and their derivatives before they can be widely used as therapeutic agents.

Bile acids and salts are naturally occurring steroidal compounds that play a crucial role in the digestion and absorption of lipids (fats) in the body. They are produced in the liver from cholesterol and then conjugated with glycine or taurine to form bile acids, which are subsequently converted into bile salts by the addition of a sodium or potassium ion.

Bile acids and salts are stored in the gallbladder and released into the small intestine during digestion, where they help emulsify fats, allowing them to be broken down into smaller molecules that can be absorbed by the body. They also aid in the elimination of waste products from the liver and help regulate cholesterol metabolism.

Abnormalities in bile acid synthesis or transport can lead to various medical conditions, such as cholestatic liver diseases, gallstones, and diarrhea. Therefore, understanding the role of bile acids and salts in the body is essential for diagnosing and treating these disorders.

Lithocholic acid (LCA) is a secondary bile acid that is produced in the liver by bacterial modification of primary bile acids, specifically chenodeoxycholic acid. It is a steroid acid that plays a role in various physiological processes such as cholesterol metabolism, drug absorption, and gut microbiota regulation. However, high levels of LCA can be toxic to the liver and have been linked to several diseases, including colon cancer and cholestatic liver diseases.

Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid that is used medically as a therapeutic agent. It is commonly used to treat gallstones, particularly cholesterol gallstones, and other conditions associated with abnormal liver function, such as primary biliary cholangitis (PBC). UDCA works by decreasing the amount of cholesterol in bile and protecting liver cells from damage. It is also known as ursodiol or Ursotan.

Deoxycholic acid is a bile acid, which is a natural molecule produced in the liver and released into the intestine to aid in the digestion of fats. It is also a secondary bile acid, meaning that it is formed from the metabolism of primary bile acids by bacteria in the gut.

Deoxycholic acid has a chemical formula of C~24~H~39~NO~4~ and a molecular weight of 391.57 g/mol. It is a white crystalline powder that is soluble in water and alcohol. In the body, deoxycholic acid acts as a detergent to help break down dietary fats into smaller droplets, which can then be absorbed by the intestines.

In addition to its role in digestion, deoxycholic acid has been investigated for its potential therapeutic uses. For example, it is approved by the US Food and Drug Administration (FDA) as an injectable treatment for reducing fat in the submental area (the region below the chin), under the brand name Kybella. When injected into this area, deoxycholic acid causes the destruction of fat cells, which are then naturally eliminated from the body over time.

It's important to note that while deoxycholic acid is a natural component of the human body, its therapeutic use can have potential side effects and risks, so it should only be used under the supervision of a qualified healthcare professional.

Cholic acid is a primary bile acid, which is a type of organic compound that plays a crucial role in the digestion and absorption of fats and fat-soluble vitamins in the body. It is produced in the liver from cholesterol and is then conjugated with glycine or taurine to form conjugated bile acids, which are stored in the gallbladder and released into the small intestine during digestion.

Cholic acid helps to emulsify fats, allowing them to be broken down into smaller droplets that can be absorbed by the body. It also facilitates the absorption of fat-soluble vitamins such as vitamin A, D, E, and K. In addition to its role in digestion, cholic acid is also involved in the regulation of cholesterol metabolism and the excretion of bile acids from the body.

Abnormalities in cholic acid metabolism can lead to various medical conditions, such as cholestatic liver diseases, gallstones, and genetic disorders that affect bile acid synthesis.

Bile is a digestive fluid that is produced by the liver and stored in the gallbladder. It plays an essential role in the digestion and absorption of fats and fat-soluble vitamins in the small intestine. Bile consists of bile salts, bilirubin, cholesterol, phospholipids, electrolytes, and water.

Bile salts are amphipathic molecules that help to emulsify fats into smaller droplets, increasing their surface area and allowing for more efficient digestion by enzymes such as lipase. Bilirubin is a breakdown product of hemoglobin from red blood cells and gives bile its characteristic greenish-brown color.

Bile is released into the small intestine in response to food, particularly fats, entering the digestive tract. It helps to break down large fat molecules into smaller ones that can be absorbed through the walls of the intestines and transported to other parts of the body for energy or storage.

Cholelithiasis is a medical term that refers to the presence of gallstones in the gallbladder. The gallbladder is a small pear-shaped organ located beneath the liver that stores bile, a digestive fluid produced by the liver. Gallstones are hardened deposits that can form in the gallbladder when substances in the bile, such as cholesterol or bilirubin, crystallize.

Gallstones can vary in size and may be as small as a grain of sand or as large as a golf ball. Some people with gallstones may not experience any symptoms, while others may have severe abdominal pain, nausea, vomiting, fever, and jaundice (yellowing of the skin and eyes) if the gallstones block the bile ducts.

Cholelithiasis is a common condition that affects millions of people worldwide, particularly women over the age of 40 and those with certain medical conditions such as obesity, diabetes, and rapid weight loss. If left untreated, gallstones can lead to serious complications such as inflammation of the gallbladder (cholecystitis), infection, or pancreatitis (inflammation of the pancreas). Treatment options for cholelithiasis include medication, shock wave lithotripsy (breaking up the gallstones with sound waves), and surgery to remove the gallbladder (cholecystectomy).

Cerebrotendinous xanthomatosis is a rare inherited genetic disorder that affects the metabolism of cholesterol and bile acids. It is caused by mutations in the CYP27A1 gene, which provides instructions for making an enzyme called sterol 27-hydroxylase that plays a crucial role in the conversion of cholesterol to bile acids.

As a result of this enzyme deficiency, there is an accumulation of cholesterol and its derivatives (particularly cholestanol) in various tissues and body fluids, leading to the formation of xanthomas, which are yellowish, fatty deposits that can be found under the skin, around the eyes, or in tendons.

Cerebrotendinous xanthomatosis primarily affects the nervous system, particularly the brain (cerebro-) and the tendons (-tendinous). The neurological symptoms may include chronic diarrhea, seizures, intellectual disability, ataxia (loss of balance and coordination), psychiatric disorders, and pyramidal signs (such as muscle weakness, spasticity, and hyperreflexia).

The accumulation of cholestanol in the brain can lead to progressive neurological deterioration, while the tendon xanthomas are typically found in the Achilles tendons. The diagnosis of cerebrotendinous xanthomatosis is usually confirmed through genetic testing and biochemical tests that measure the levels of cholestanol and bile acids in the blood or other body fluids.

Early diagnosis and treatment with a medication called chenodeoxycholic acid, which helps to lower cholesterol levels and reduce xanthoma formation, can significantly improve the prognosis and quality of life for individuals with cerebrotendinous xanthomatosis.

Cholestanols are a type of sterol that is similar in structure to cholesterol. They are found in small amounts in the body and can also be found in some foods. Cholestanols are formed when cholesterol undergoes a chemical reaction called isomerization, which changes its structure.

Cholestanols are important because they can accumulate in the body and contribute to the development of certain medical conditions. For example, elevated levels of cholestanols in the blood have been associated with an increased risk of cardiovascular disease. Additionally, some genetic disorders can cause an accumulation of cholestanols in various tissues, leading to a range of symptoms such as liver damage, neurological problems, and cataracts.

Medically, cholestanols are often used as markers for the diagnosis and monitoring of certain conditions related to cholesterol metabolism.

I'm sorry for any confusion, but "Glycocholic Acid" is not a widely recognized or established medical term. It seems there might be a misunderstanding or a typo in your request.

If you meant "Glycocholic," it's a term that refers to a substance conjugated with glycine, which is an amino acid. This process often occurs in the liver during the metabolism of certain substances, like bile acids.

"Glycocholic" could theoretically refer to a glycine conjugate of a bile acid such as cholic acid, which would make it a derivative called "Glycocholic Acid." However, I couldn't find any specific medical or scientific literature that directly refers to "Glycocholic Acid" as a known compound or concept.

If you could provide more context or clarify your question, I would be happy to help further!

Xanthomatosis is a medical term that refers to the condition characterized by the presence of xanthomas, which are yellowish, fat-laden deposits that form under the skin or in other tissues. These deposits consist of lipids, such as cholesterol and triglycerides, and immune cells called macrophages, which have engulfed the lipids.

Xanthomas can occur in various parts of the body, including the eyelids, tendons, joints, and other areas with connective tissue. They may appear as small papules or larger nodules, and their size and number can vary depending on the severity of the underlying disorder.

Xanthomatosis is often associated with genetic disorders that affect lipid metabolism, such as familial hypercholesterolemia, or with acquired conditions that cause high levels of lipids in the blood, such as diabetes, hypothyroidism, and certain liver diseases. Treatment typically involves addressing the underlying disorder and controlling lipid levels through dietary changes, medications, or a combination of both.

Cholagogues and choleretics are terms used to describe medications or substances that affect bile secretion and flow in the body. Here is a medical definition for each:

1. Cholagogue: A substance that promotes the discharge of bile from the gallbladder into the duodenum, often by stimulating the contraction of the gallbladder muscle. This helps in the digestion and absorption of fats. Examples include chenodeoxycholic acid, ursodeoxycholic acid, and some herbal remedies like dandelion root and milk thistle.
2. Choleretic: A substance that increases the production of bile by the liver or its flow through the biliary system. This can help with the digestion of fats and the elimination of waste products from the body. Examples include certain medications like ursodeoxycholic acid, as well as natural substances such as lemon juice, artichoke extract, and turmeric.

It is important to note that while cholagogues and choleretics can aid in digestion, they should be used under the guidance of a healthcare professional, as improper use or overuse may lead to complications like diarrhea or gallstone formation.

Cholestenones are a group of steroid compounds that are derived from cholesterol. They include several biologically important compounds, such as bile acids and their intermediates, which play crucial roles in the digestion and absorption of fats and fat-soluble vitamins. Cholestenones are also used as intermediates in the synthesis of various steroid hormones, including cortisol, aldosterone, and sex hormones.

Cholestenones are characterized by a carbon skeleton consisting of four fused rings, with a double bond between the second and third carbons and a ketone group at the third carbon atom. Some examples of cholestenones include 7-dehydrocholesterol, which is a precursor to vitamin D, and desmosterol, which is an intermediate in the biosynthesis of cholesterol.

It's worth noting that while cholestenones are important biomolecules, they can also accumulate in various tissues and fluids under certain pathological conditions, such as in some inherited metabolic disorders. For example, elevated levels of certain cholestenones in the blood or urine may indicate the presence of Smith-Lemli-Opitz syndrome, a genetic disorder that affects cholesterol biosynthesis.

Cholestanes are a type of steroid compound that are derived from cholesterol. They are characterized by a fully saturated steroid nucleus, which means that all of the double bonds in the cholesterol molecule have been reduced to single bonds through a process called hydrogenation.

Cholestanes are important intermediates in the biosynthesis of other steroids, such as bile acids and steroid hormones. They can also be found in some natural sources, including certain plants and fungi.

It's worth noting that cholestanes themselves do not have any specific medical significance, but they are important for understanding the biochemistry of steroids and their role in human health and disease.

Steroid 12-alpha-hydroxylase is an enzyme that is involved in the metabolism of steroids. It is specifically responsible for adding a hydroxyl group (-OH) to the 12th carbon atom of certain steroid molecules. This enzyme plays a crucial role in the biosynthesis of bile acids and corticosteroids, including cortisol and aldosterone, which are important hormones produced by the adrenal gland.

The gene that encodes this enzyme is called CYP12A1, and mutations in this gene can lead to various disorders related to steroid metabolism. For example, a deficiency in steroid 12-alpha-hydroxylase can result in the accumulation of bile acids that are not properly hydroxylated, which can cause liver damage and cholestatic pruritus (itching). Additionally, impaired cortisol and aldosterone production due to defects in this enzyme can lead to conditions such as congenital adrenal hyperplasia and salt-wasting crisis.

Cholesterol is a type of lipid (fat) molecule that is an essential component of cell membranes and is also used to make certain hormones and vitamins in the body. It is produced by the liver and is also obtained from animal-derived foods such as meat, dairy products, and eggs.

Cholesterol does not mix with blood, so it is transported through the bloodstream by lipoproteins, which are particles made up of both lipids and proteins. There are two main types of lipoproteins that carry cholesterol: low-density lipoproteins (LDL), also known as "bad" cholesterol, and high-density lipoproteins (HDL), also known as "good" cholesterol.

High levels of LDL cholesterol in the blood can lead to a buildup of cholesterol in the walls of the arteries, increasing the risk of heart disease and stroke. On the other hand, high levels of HDL cholesterol are associated with a lower risk of these conditions because HDL helps remove LDL cholesterol from the bloodstream and transport it back to the liver for disposal.

It is important to maintain healthy levels of cholesterol through a balanced diet, regular exercise, and sometimes medication if necessary. Regular screening is also recommended to monitor cholesterol levels and prevent health complications.

I'm sorry for any confusion, but "Cholenes" is not a recognized medical term or abbreviation in English. It's possible that there may be a spelling mistake or it could be a term specific to a certain language or field of study. If you have more context or information, I'd be happy to help further!

Hydroxysteroid dehydrogenases (HSDs) are a group of enzymes that play a crucial role in steroid hormone metabolism. They catalyze the oxidation and reduction reactions of hydroxyl groups on the steroid molecule, which can lead to the activation or inactivation of steroid hormones. HSDs are involved in the conversion of various steroids, including sex steroids (e.g., androgens, estrogens) and corticosteroids (e.g., cortisol, cortisone). These enzymes can be found in different tissues throughout the body, and their activity is regulated by various factors, such as hormones, growth factors, and cytokines. Dysregulation of HSDs has been implicated in several diseases, including cancer, diabetes, and cardiovascular disease.

Glycochenodeoxycholic acid (GCDCA) is a type of bile acid that is produced in the liver and then conjugated with glycine. Bile acids are formed from cholesterol and play an important role in the digestion and absorption of fats and fat-soluble vitamins in the small intestine.

GCDCA is a secondary bile acid, which means that it is produced by bacterial metabolism of primary bile acids (such as cholic acid and chenodeoxycholic acid) in the colon. Once formed, GCDCA is then reabsorbed into the bloodstream and transported back to the liver, where it can be conjugated with glycine or taurine and excreted into bile again.

Abnormal levels of GCDCA and other bile acids have been associated with various health conditions, including cholestatic liver diseases, gallstones, and colon cancer. Therefore, measuring the levels of these acids in blood, urine, or feces can provide valuable diagnostic information for these conditions.

Steroid hydroxylases are enzymes that catalyze the addition of a hydroxyl group (-OH) to a steroid molecule. These enzymes are located in the endoplasmic reticulum and play a crucial role in the biosynthesis of various steroid hormones, such as cortisol, aldosterone, and sex hormones. The hydroxylation reaction catalyzed by these enzymes increases the polarity and solubility of steroids, allowing them to be further metabolized and excreted from the body.

The most well-known steroid hydroxylases are part of the cytochrome P450 family, specifically CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP19A1, and CYP21A2. Each enzyme has a specific function in steroid biosynthesis, such as converting cholesterol to pregnenolone (CYP11A1), hydroxylating the 11-beta position of steroids (CYP11B1 and CYP11B2), or performing multiple hydroxylation reactions in the synthesis of sex hormones (CYP17A1, CYP19A1, and CYP21A2).

Defects in these enzymes can lead to various genetic disorders, such as congenital adrenal hyperplasia, which is characterized by impaired steroid hormone biosynthesis.

Enterohepatic circulation is the process by which certain substances, such as bile salts, bilirubin, and some drugs, are chemically modified and reabsorbed in the enterohepatic system. This system includes the liver, bile ducts, and small intestine.

In the case of bile salts, they are synthesized in the liver, secreted into the bile, and stored in the gallbladder. After a meal, the gallbladder contracts and releases bile into the small intestine to aid in fat digestion. The bile salts help to emulsify fats, allowing them to be absorbed by the intestines. Once absorbed, they are transported back to the liver through the portal vein, where they can be reused for further bile production.

Similarly, bilirubin, a waste product produced from the breakdown of red blood cells, is also conjugated in the liver and excreted into the bile. In the small intestine, bacteria break down bilirubin into colorless urobilinogen, which can be reabsorbed and transported back to the liver for further processing.

Certain drugs may also undergo enterohepatic circulation, where they are metabolized in the liver, excreted into the bile, and then reabsorbed in the small intestine. This can prolong the duration of drug action and affect its overall effectiveness.

Cholestanol is a sterol that is similar in structure to cholesterol. It is produced in the body as a byproduct of cholesterol metabolism and can be found in various tissues, including the liver, blood, and nervous system.

Cholestanol is not normally present in large amounts in the body, but elevated levels can indicate the presence of certain genetic disorders or conditions that affect cholesterol metabolism, such as cerebrotendinous xanthomatosis (CTX). In CTX, mutations in the gene for the enzyme sterol 27-hydroxylase lead to an accumulation of cholestanol and other sterols in various tissues, which can cause a range of symptoms including neurological problems, cataracts, and tendon xanthomas (cholesterol deposits).

Elevated levels of cholestanol can also be found in some other conditions, such as liver disease or bile acid synthesis disorders. Therefore, measuring cholestanol levels in the blood may be useful as a diagnostic tool for these conditions.

Cholesterol 7-alpha-hydroxylase (CYP7A1) is an enzyme that plays a crucial role in the regulation of cholesterol homeostasis in the body. It is located in the endoplasmic reticulum of hepatic cells and is responsible for the rate-limiting step in the synthesis of bile acids from cholesterol.

The enzyme catalyzes the conversion of cholesterol to 7α-hydroxycholesterol, which is then further metabolized to form primary bile acids, including cholic acid and chenodeoxycholic acid. These bile acids are essential for the digestion and absorption of fats and fat-soluble vitamins in the small intestine.

Additionally, CYP7A1 is also involved in the regulation of cholesterol levels in the body by providing negative feedback to the synthesis of cholesterol in the liver. When cholesterol levels are high, the activity of CYP7A1 increases, leading to an increase in bile acid synthesis and a decrease in cholesterol levels. Conversely, when cholesterol levels are low, the activity of CYP7A1 decreases, reducing bile acid synthesis and allowing cholesterol levels to rise.

Abnormalities in CYP7A1 function have been implicated in several diseases, including gallstones, liver disease, and cardiovascular disease.

Taurochenodeoxycholic acid (TCDCA) is a bile acid that is conjugated with the amino acid taurine. Bile acids are synthesized from cholesterol in the liver and released into the small intestine to aid in the digestion and absorption of fats and fat-soluble vitamins. TCDCA, along with other bile acids, is reabsorbed in the terminal ileum and transported back to the liver through the enterohepatic circulation. It plays a role in maintaining cholesterol homeostasis and has been studied for its potential therapeutic effects in various medical conditions, including gallstones, cholestatic liver diseases, and neurological disorders.

The gallbladder is a small, pear-shaped organ located just under the liver in the right upper quadrant of the abdomen. Its primary function is to store and concentrate bile, a digestive enzyme produced by the liver, which helps in the breakdown of fats during the digestion process. When food, particularly fatty foods, enter the stomach and small intestine, the gallbladder contracts and releases bile through the common bile duct into the duodenum, the first part of the small intestine, to aid in fat digestion.

The gallbladder is made up of three main parts: the fundus, body, and neck. It has a muscular wall that allows it to contract and release bile. Gallstones, an inflammation of the gallbladder (cholecystitis), or other gallbladder diseases can cause pain, discomfort, and potentially serious health complications if left untreated.

Taurocholic acid is a bile salt, which is a type of organic compound that plays a crucial role in the digestion and absorption of fats and fat-soluble vitamins in the small intestine. It is formed in the liver by conjugation of cholic acid with taurine, an amino sulfonic acid.

Taurocholic acid has a detergent-like effect on the lipids in our food, helping to break them down into smaller molecules that can be absorbed through the intestinal wall and transported to other parts of the body for energy production or storage. It also helps to maintain the flow of bile from the liver to the gallbladder and small intestine, where it is stored until needed for digestion.

Abnormal levels of taurocholic acid in the body have been linked to various health conditions, including gallstones, liver disease, and gastrointestinal disorders. Therefore, it is important to maintain a healthy balance of bile salts, including taurocholic acid, for optimal digestive function.

Gas Chromatography-Mass Spectrometry (GC-MS) is a powerful analytical technique that combines the separating power of gas chromatography with the identification capabilities of mass spectrometry. This method is used to separate, identify, and quantify different components in complex mixtures.

In GC-MS, the mixture is first vaporized and carried through a long, narrow column by an inert gas (carrier gas). The various components in the mixture interact differently with the stationary phase inside the column, leading to their separation based on their partition coefficients between the mobile and stationary phases. As each component elutes from the column, it is then introduced into the mass spectrometer for analysis.

The mass spectrometer ionizes the sample, breaks it down into smaller fragments, and measures the mass-to-charge ratio of these fragments. This information is used to generate a mass spectrum, which serves as a unique "fingerprint" for each compound. By comparing the generated mass spectra with reference libraries or known standards, analysts can identify and quantify the components present in the original mixture.

GC-MS has wide applications in various fields such as forensics, environmental analysis, drug testing, and research laboratories due to its high sensitivity, specificity, and ability to analyze volatile and semi-volatile compounds.

I am not aware of a medical term called "Cholanes." The term may be misspelled or it might refer to a specific concept or substance within a particular context. In general, "chol"-related terms in medicine refer to bile or the biliary system. For example, "chole" means bile and "cholestasis" refers to the stoppage of bile flow. If you have more context or information about where this term is being used, I'd be happy to help you try to decipher it further!

"Eubacterium" is a genus of Gram-positive, obligately anaerobic, non-sporeforming bacteria that are commonly found in the human gastrointestinal tract. These bacteria are typically rod-shaped and can be either straight or curved. They play an important role in the breakdown of complex carbohydrates and the production of short-chain fatty acids in the gut, which are beneficial for host health. Some species of Eubacterium have also been shown to have probiotic properties and may provide health benefits when consumed in appropriate quantities. However, other species can be opportunistic pathogens and cause infections under certain circumstances.

Cholestasis is a medical condition characterized by the interruption or reduction of bile flow from the liver to the small intestine. Bile is a digestive fluid produced by the liver that helps in the breakdown and absorption of fats. When the flow of bile is blocked or reduced, it can lead to an accumulation of bile components, such as bilirubin, in the blood, which can cause jaundice, itching, and other symptoms.

Cholestasis can be caused by various factors, including liver diseases (such as hepatitis, cirrhosis, or cancer), gallstones, alcohol abuse, certain medications, pregnancy, and genetic disorders. Depending on the underlying cause, cholestasis may be acute or chronic, and it can range from mild to severe in its symptoms and consequences. Treatment for cholestasis typically involves addressing the underlying cause and managing the symptoms with supportive care.

Dehydrocholic acid is not typically considered a medical term, but it does have relevance to the field of medicine as a gastrointestinal stimulant and choleretic agent. Here's a brief definition:

Dehydrocholic acid (C~24~H~39~NO~5~) is a bile salt that is formed from cholic acid through the introduction of a double bond between carbons 7 and 8. It is used in medical research and practice as a pharmacological agent to stimulate the production and flow of bile from the liver, which can aid in digestion and absorption of fats. Dehydrocholic acid may also be used in diagnostic tests to assess liver function and biliary tract patency.

It is important to note that dehydrocholic acid is not commonly used as a therapeutic agent in clinical practice due to the availability of safer and more effective alternatives for treating gastrointestinal disorders and promoting liver health.

Cholestanetriol 26-monooxygenase is an enzyme that is involved in the metabolism of bile acids and steroids in the body. This enzyme is responsible for adding a hydroxyl group (-OH) to the cholestanetriol molecule at position 26, which is a critical step in the conversion of cholestanetriol to bile acids.

The gene that encodes this enzyme is called CYP3A4, which is located on chromosome 7 in humans. Mutations in this gene can lead to various metabolic disorders, including impaired bile acid synthesis and altered steroid hormone metabolism.

Deficiency or dysfunction of cholestanetriol 26-monooxygenase has been associated with several diseases, such as liver disease, cerebrotendinous xanthomatosis, and some forms of cancer. Therefore, understanding the function and regulation of this enzyme is essential for developing new therapies and treatments for these conditions.

Feces are the solid or semisolid remains of food that could not be digested or absorbed in the small intestine, along with bacteria and other waste products. After being stored in the colon, feces are eliminated from the body through the rectum and anus during defecation. Feces can vary in color, consistency, and odor depending on a person's diet, health status, and other factors.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

Cholecystography is a medical procedure that involves the use of X-rays to examine the gallbladder and bile ducts. It is also known as an oral cholecystogram (OCG).

The procedure involves administering a contrast agent, typically a iodine-based dye, which is absorbed by the liver and excreted into the bile ducts and gallbladder. The dye makes the bile ducts and gallbladder visible on X-ray images, allowing doctors to diagnose conditions such as gallstones, tumors, or inflammation of the gallbladder.

Cholecystography is not commonly used today due to the development of more advanced imaging techniques, such as ultrasound and computed tomography (CT) scans, which are non-invasive and do not require the use of contrast agents. However, it may still be used in certain cases where other imaging tests are inconclusive or unavailable.

Cholestyramine resin is a medication used to treat high levels of cholesterol in the blood. It is a type of drug called a bile acid sequestrant, which works by binding to bile acids in the digestive system and preventing them from being reabsorbed into the body. This leads to an increased removal of cholesterol from the body, which can help lower the levels of cholesterol in the blood.

Cholestyramine resin is available as a powder that is mixed with water or other fluids and taken by mouth. It may be used alone or in combination with other medications to treat high cholesterol. In addition to its use for lowering cholesterol, cholestyramine resin may also be used to treat itching associated with partial biliary obstruction (blockage of the bile ducts) and to reduce the absorption of certain drugs, such as digitalis and thyroid hormones.

It is important to follow the instructions of a healthcare provider when taking cholestyramine resin, as the medication can interfere with the absorption of other medications and nutrients. It may also cause gastrointestinal side effects, such as constipation, bloating, and gas.

Chromatography, gas (GC) is a type of chromatographic technique used to separate, identify, and analyze volatile compounds or vapors. In this method, the sample mixture is vaporized and carried through a column packed with a stationary phase by an inert gas (carrier gas). The components of the mixture get separated based on their partitioning between the mobile and stationary phases due to differences in their adsorption/desorption rates or solubility.

The separated components elute at different times, depending on their interaction with the stationary phase, which can be detected and quantified by various detection systems like flame ionization detector (FID), thermal conductivity detector (TCD), electron capture detector (ECD), or mass spectrometer (MS). Gas chromatography is widely used in fields such as chemistry, biochemistry, environmental science, forensics, and food analysis.

Cytoplasmic receptors and nuclear receptors are two types of intracellular receptors that play crucial roles in signal transduction pathways and regulation of gene expression. They are classified based on their location within the cell. Here are the medical definitions for each:

1. Cytoplasmic Receptors: These are a group of intracellular receptors primarily found in the cytoplasm of cells, which bind to specific hormones, growth factors, or other signaling molecules. Upon binding, these receptors undergo conformational changes that allow them to interact with various partners, such as adapter proteins and enzymes, leading to activation of downstream signaling cascades. These pathways ultimately result in modulation of cellular processes like proliferation, differentiation, and apoptosis. Examples of cytoplasmic receptors include receptor tyrosine kinases (RTKs), serine/threonine kinase receptors, and cytokine receptors.
2. Nuclear Receptors: These are a distinct class of intracellular receptors that reside primarily in the nucleus of cells. They bind to specific ligands, such as steroid hormones, thyroid hormones, vitamin D, retinoic acid, and various other lipophilic molecules. Upon binding, nuclear receptors undergo conformational changes that facilitate their interaction with co-regulatory proteins and the DNA. This interaction results in the modulation of gene transcription, ultimately leading to alterations in protein expression and cellular responses. Examples of nuclear receptors include estrogen receptor (ER), androgen receptor (AR), glucocorticoid receptor (GR), thyroid hormone receptor (TR), vitamin D receptor (VDR), and peroxisome proliferator-activated receptors (PPARs).

Both cytoplasmic and nuclear receptors are essential components of cellular communication networks, allowing cells to respond appropriately to extracellular signals and maintain homeostasis. Dysregulation of these receptors has been implicated in various diseases, including cancer, diabetes, and autoimmune disorders.

Gastrointestinal agents are a class of pharmaceutical drugs that affect the gastrointestinal (GI) tract, which includes the organs involved in digestion such as the mouth, esophagus, stomach, small intestine, large intestine, and anus. These agents can have various effects on the GI tract, including:

1. Increasing gastric motility (promoting bowel movements) - laxatives, prokinetics
2. Decreasing gastric motility (reducing bowel movements) - antidiarrheal agents
3. Neutralizing gastric acid - antacids
4. Reducing gastric acid secretion - H2-blockers, proton pump inhibitors
5. Protecting the mucosal lining of the GI tract - sucralfate, misoprostol
6. Relieving symptoms associated with GI disorders such as bloating, abdominal pain, and nausea - antispasmodics, antiemetics

Examples of gastrointestinal agents include:

* Laxatives (e.g., psyllium, docusate)
* Prokinetics (e.g., metoclopramide)
* Antacids (e.g., calcium carbonate, aluminum hydroxide)
* H2-blockers (e.g., ranitidine, famotidine)
* Proton pump inhibitors (e.g., omeprazole, lansoprazole)
* Sucralfate
* Misoprostol
* Antispasmodics (e.g., hyoscyamine, dicyclomine)
* Antiemetics (e.g., ondansetron, promethazine)

It is important to note that gastrointestinal agents can have both therapeutic and adverse effects, and their use should be based on a careful evaluation of the patient's condition and medical history.

Taurine is an organic compound that is widely distributed in animal tissues. It is a conditionally essential amino acid, meaning it can be synthesized by the human body under normal circumstances, but there may be increased requirements during certain periods such as infancy, infection, or illness. Taurine plays important roles in various physiological functions, including bile salt formation, membrane stabilization, neuromodulation, and antioxidation. It is particularly abundant in the brain, heart, retina, and skeletal muscles. In the human body, taurine is synthesized from the amino acids cysteine and methionine with the aid of vitamin B6.

Taurine can also be found in certain foods like meat, fish, and dairy products, as well as in energy drinks, where it is often added as a supplement for its potential performance-enhancing effects. However, there is ongoing debate about the safety and efficacy of taurine supplementation in healthy individuals.

Thin-layer chromatography (TLC) is a type of chromatography used to separate, identify, and quantify the components of a mixture. In TLC, the sample is applied as a small spot onto a thin layer of adsorbent material, such as silica gel or alumina, which is coated on a flat, rigid support like a glass plate. The plate is then placed in a developing chamber containing a mobile phase, typically a mixture of solvents.

As the mobile phase moves up the plate by capillary action, it interacts with the stationary phase and the components of the sample. Different components of the mixture travel at different rates due to their varying interactions with the stationary and mobile phases, resulting in distinct spots on the plate. The distance each component travels can be measured and compared to known standards to identify and quantify the components of the mixture.

TLC is a simple, rapid, and cost-effective technique that is widely used in various fields, including forensics, pharmaceuticals, and research laboratories. It allows for the separation and analysis of complex mixtures with high resolution and sensitivity, making it an essential tool in many analytical applications.

Hydroxycholesterols are a type of sterol that is formed in the body when cholesterol, a steroid alcohol, undergoes hydroxylation. This means that one or more hydroxyl groups (-OH) are added to the cholesterol molecule. There are several different types of hydroxycholesterols, including 24-hydroxycholesterol, 25-hydroxycholesterol, and 27-hydroxycholesterol, among others. These compounds play important roles in various physiological processes, such as regulating cholesterol metabolism and contributing to the formation of bile acids. They have also been studied for their potential involvement in atherosclerosis, Alzheimer's disease, and other health conditions.

"Mesocricetus" is a genus of rodents, more commonly known as hamsters. It includes several species of hamsters that are native to various parts of Europe and Asia. The best-known member of this genus is the Syrian hamster, also known as the golden hamster or Mesocricetus auratus, which is a popular pet due to its small size and relatively easy care. These hamsters are burrowing animals and are typically solitary in the wild.

Cholecystectomy is a medical procedure to remove the gallbladder, a small pear-shaped organ located on the right side of the abdomen, just beneath the liver. The primary function of the gallbladder is to store and concentrate bile, a digestive fluid produced by the liver. During a cholecystectomy, the surgeon removes the gallbladder, usually due to the presence of gallstones or inflammation that can cause pain, infection, or other complications.

There are two primary methods for performing a cholecystectomy:

1. Open Cholecystectomy: In this traditional surgical approach, the surgeon makes an incision in the abdomen to access and remove the gallbladder. This method is typically used when there are complications or unique circumstances that make laparoscopic surgery difficult or risky.
2. Laparoscopic Cholecystectomy: This is a minimally invasive surgical procedure where the surgeon makes several small incisions in the abdomen, through which a thin tube with a camera (laparoscope) and specialized surgical instruments are inserted. The surgeon then guides these tools to remove the gallbladder while viewing the internal structures on a video monitor.

After the gallbladder is removed, bile flows directly from the liver into the small intestine through the common bile duct, and the body continues to function normally without any significant issues.

A biliary fistula is an abnormal connection or passage between the biliary system (which includes the gallbladder, bile ducts, and liver) and another organ or structure, usually in the abdominal cavity. This connection allows bile, which is a digestive fluid produced by the liver, to leak out of its normal pathway and into other areas of the body.

Biliary fistulas can occur as a result of trauma, surgery, infection, or inflammation in the biliary system. Symptoms may include abdominal pain, fever, jaundice (yellowing of the skin and eyes), nausea, vomiting, and clay-colored stools. Treatment typically involves addressing the underlying cause of the fistula, such as draining an infection or repairing damaged tissue, and diverting bile flow away from the site of the leak. In some cases, surgery may be necessary to repair the fistula.

Biotransformation is the metabolic modification of a chemical compound, typically a xenobiotic (a foreign chemical substance found within an living organism), by a biological system. This process often involves enzymatic conversion of the parent compound to one or more metabolites, which may be more or less active, toxic, or mutagenic than the original substance.

In the context of pharmacology and toxicology, biotransformation is an important aspect of drug metabolism and elimination from the body. The liver is the primary site of biotransformation, but other organs such as the kidneys, lungs, and gastrointestinal tract can also play a role.

Biotransformation can occur in two phases: phase I reactions involve functionalization of the parent compound through oxidation, reduction, or hydrolysis, while phase II reactions involve conjugation of the metabolite with endogenous molecules such as glucuronic acid, sulfate, or acetate to increase its water solubility and facilitate excretion.

Microsomes, liver refers to a subcellular fraction of liver cells (hepatocytes) that are obtained during tissue homogenization and subsequent centrifugation. These microsomal fractions are rich in membranous structures known as the endoplasmic reticulum (ER), particularly the rough ER. They are involved in various important cellular processes, most notably the metabolism of xenobiotics (foreign substances) including drugs, toxins, and carcinogens.

The liver microsomes contain a variety of enzymes, such as cytochrome P450 monooxygenases, that are crucial for phase I drug metabolism. These enzymes help in the oxidation, reduction, or hydrolysis of xenobiotics, making them more water-soluble and facilitating their excretion from the body. Additionally, liver microsomes also host other enzymes involved in phase II conjugation reactions, where the metabolites from phase I are further modified by adding polar molecules like glucuronic acid, sulfate, or acetyl groups.

In summary, liver microsomes are a subcellular fraction of liver cells that play a significant role in the metabolism and detoxification of xenobiotics, contributing to the overall protection and maintenance of cellular homeostasis within the body.

Sitosterols are a type of plant sterol or phytosterol that are structurally similar to cholesterol, a steroid lipid found in animals. They are found in small amounts in human diets, primarily in vegetable oils, nuts, seeds, and avocados. Sitosterols are not synthesized by the human body but can be absorbed from the diet and have been shown to lower cholesterol levels in the blood when consumed in sufficient quantities. This is because sitosterols compete with cholesterol for absorption in the digestive tract, reducing the amount of cholesterol that enters the bloodstream. Some margarines and other foods are fortified with sitosterols or other phytosterols to help reduce cholesterol levels in people with high cholesterol.

Carbadox is a veterinary drug that belongs to the class of medications called antimicrobials. It is specifically an antimicrobial agent with both antibacterial and coccidiostat properties. Carbadox is used in the treatment and prevention of certain bacterial infections in swine (pigs). It works by inhibiting the growth of bacteria and killing coccidia, a type of parasite that can cause infection in pigs.

Carbadox is available as a feed additive and is typically administered to pigs through their food. It is important to note that carbadox is not approved for use in animals destined for human consumption in many countries, including the European Union, due to concerns about potential carcinogenicity and other safety issues.

It's worth mentioning that the use of carbadox in food-producing animals has been a topic of controversy and debate in recent years, with some experts calling for stricter regulations or a complete ban on its use due to concerns about antibiotic resistance and human health.

Isoxazoles are not a medical term, but a chemical compound. They are organic compounds containing a five-membered ring consisting of one nitrogen atom, one oxygen atom, and three carbon atoms. Isoxazoles have various applications in the pharmaceutical industry as they can be used to synthesize different drugs. Some isoxazole derivatives have been studied for their potential medicinal properties, such as anti-inflammatory, analgesic, and antipyretic effects. However, isoxazoles themselves are not a medical diagnosis or treatment.

Inborn errors of lipid metabolism refer to genetic disorders that affect the body's ability to break down and process lipids (fats) properly. These disorders are caused by defects in genes that code for enzymes or proteins involved in lipid metabolism. As a result, toxic levels of lipids or their intermediates may accumulate in the body, leading to various health issues, which can include neurological problems, liver dysfunction, muscle weakness, and cardiovascular disease.

There are several types of inborn errors of lipid metabolism, including:

1. Disorders of fatty acid oxidation: These disorders affect the body's ability to convert long-chain fatty acids into energy, leading to muscle weakness, hypoglycemia, and cardiomyopathy. Examples include medium-chain acyl-CoA dehydrogenase deficiency (MCAD) and very long-chain acyl-CoA dehydrogenase deficiency (VLCAD).
2. Disorders of cholesterol metabolism: These disorders affect the body's ability to process cholesterol, leading to an accumulation of cholesterol or its intermediates in various tissues. Examples include Smith-Lemli-Opitz syndrome and lathosterolosis.
3. Disorders of sphingolipid metabolism: These disorders affect the body's ability to break down sphingolipids, leading to an accumulation of these lipids in various tissues. Examples include Gaucher disease, Niemann-Pick disease, and Fabry disease.
4. Disorders of glycerophospholipid metabolism: These disorders affect the body's ability to break down glycerophospholipids, leading to an accumulation of these lipids in various tissues. Examples include rhizomelic chondrodysplasia punctata and abetalipoproteinemia.

Inborn errors of lipid metabolism are typically diagnosed through genetic testing and biochemical tests that measure the activity of specific enzymes or the levels of specific lipids in the body. Treatment may include dietary modifications, supplements, enzyme replacement therapy, or gene therapy, depending on the specific disorder and its severity.

Carbon radioisotopes are radioactive isotopes of carbon, which is an naturally occurring chemical element with the atomic number 6. The most common and stable isotope of carbon is carbon-12 (^12C), but there are also several radioactive isotopes, including carbon-11 (^11C), carbon-14 (^14C), and carbon-13 (^13C). These radioisotopes have different numbers of neutrons in their nuclei, which makes them unstable and causes them to emit radiation.

Carbon-11 has a half-life of about 20 minutes and is used in medical imaging techniques such as positron emission tomography (PET) scans. It is produced by bombarding nitrogen-14 with protons in a cyclotron.

Carbon-14, also known as radiocarbon, has a half-life of about 5730 years and is used in archaeology and geology to date organic materials. It is produced naturally in the atmosphere by cosmic rays.

Carbon-13 is stable and has a natural abundance of about 1.1% in carbon. It is not radioactive, but it can be used as a tracer in medical research and in the study of metabolic processes.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

'Clostridium' is a genus of gram-positive, rod-shaped bacteria that are widely distributed in nature, including in soil, water, and the gastrointestinal tracts of animals and humans. Many species of Clostridium are anaerobic, meaning they can grow and reproduce in environments with little or no oxygen. Some species of Clostridium are capable of producing toxins that can cause serious and sometimes life-threatening illnesses in humans and animals.

Some notable species of Clostridium include:

* Clostridium tetani, which causes tetanus (also known as lockjaw)
* Clostridium botulinum, which produces botulinum toxin, the most potent neurotoxin known and the cause of botulism
* Clostridium difficile, which can cause severe diarrhea and colitis, particularly in people who have recently taken antibiotics
* Clostridium perfringens, which can cause food poisoning and gas gangrene.

It is important to note that not all species of Clostridium are harmful, and some are even beneficial, such as those used in the production of certain fermented foods like sauerkraut and natto. However, due to their ability to produce toxins and cause illness, it is important to handle and dispose of materials contaminated with Clostridium species carefully, especially in healthcare settings.

Hydroxylation is a biochemical process that involves the addition of a hydroxyl group (-OH) to a molecule, typically a steroid or xenobiotic compound. This process is primarily catalyzed by enzymes called hydroxylases, which are found in various tissues throughout the body.

In the context of medicine and biochemistry, hydroxylation can have several important functions:

1. Drug metabolism: Hydroxylation is a common way that the liver metabolizes drugs and other xenobiotic compounds. By adding a hydroxyl group to a drug molecule, it becomes more polar and water-soluble, which facilitates its excretion from the body.
2. Steroid hormone biosynthesis: Hydroxylation is an essential step in the biosynthesis of many steroid hormones, including cortisol, aldosterone, and the sex hormones estrogen and testosterone. These hormones are synthesized from cholesterol through a series of enzymatic reactions that involve hydroxylation at various steps.
3. Vitamin D activation: Hydroxylation is also necessary for the activation of vitamin D in the body. In order to become biologically active, vitamin D must undergo two successive hydroxylations, first in the liver and then in the kidneys.
4. Toxin degradation: Some toxic compounds can be rendered less harmful through hydroxylation. For example, phenol, a toxic compound found in cigarette smoke and some industrial chemicals, can be converted to a less toxic form through hydroxylation by enzymes in the liver.

Overall, hydroxylation is an important biochemical process that plays a critical role in various physiological functions, including drug metabolism, hormone biosynthesis, and toxin degradation.

In the context of medicine, "chemistry" often refers to the field of study concerned with the properties, composition, and structure of elements and compounds, as well as their reactions with one another. It is a fundamental science that underlies much of modern medicine, including pharmacology (the study of drugs), toxicology (the study of poisons), and biochemistry (the study of the chemical processes that occur within living organisms).

In addition to its role as a basic science, chemistry is also used in medical testing and diagnosis. For example, clinical chemistry involves the analysis of bodily fluids such as blood and urine to detect and measure various substances, such as glucose, cholesterol, and electrolytes, that can provide important information about a person's health status.

Overall, chemistry plays a critical role in understanding the mechanisms of diseases, developing new treatments, and improving diagnostic tests and techniques.

Chemical phenomena refer to the changes and interactions that occur at the molecular or atomic level when chemicals are involved. These phenomena can include chemical reactions, in which one or more substances (reactants) are converted into different substances (products), as well as physical properties that change as a result of chemical interactions, such as color, state of matter, and solubility. Chemical phenomena can be studied through various scientific disciplines, including chemistry, biochemistry, and physics.

Dietary cholesterol is a type of cholesterol that comes from the foods we eat. It is present in animal-derived products such as meat, poultry, dairy products, and eggs. While dietary cholesterol can contribute to an increase in blood cholesterol levels for some people, it's important to note that saturated and trans fats have a more significant impact on blood cholesterol levels than dietary cholesterol itself.

The American Heart Association recommends limiting dietary cholesterol intake to less than 300 milligrams per day for most people, and less than 200 milligrams per day for those with a history of heart disease or high cholesterol levels. However, individual responses to dietary cholesterol can vary, so it's essential to monitor blood cholesterol levels and adjust dietary habits accordingly.

Hyperlipidemias are a group of disorders characterized by an excess of lipids (fats) or lipoproteins in the blood. These include elevated levels of cholesterol, triglycerides, or both. Hyperlipidemias can be inherited (primary) or caused by other medical conditions (secondary). They are a significant risk factor for developing cardiovascular diseases, such as atherosclerosis and coronary artery disease.

There are two main types of lipids that are commonly measured in the blood: low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol, and high-density lipoprotein (HDL) cholesterol, known as "good" cholesterol. High levels of LDL cholesterol can lead to the formation of plaques in the arteries, which can narrow or block them and increase the risk of heart attack or stroke. On the other hand, high levels of HDL cholesterol are protective because they help remove LDL cholesterol from the bloodstream.

Triglycerides are another type of lipid that can be measured in the blood. Elevated triglyceride levels can also contribute to the development of cardiovascular disease, particularly when combined with high LDL cholesterol and low HDL cholesterol levels.

Hyperlipidemias are typically diagnosed through a blood test that measures the levels of various lipids and lipoproteins in the blood. Treatment may include lifestyle changes, such as following a healthy diet, getting regular exercise, losing weight, and quitting smoking, as well as medication to lower lipid levels if necessary.

Hydroxymethylglutaryl CoA (HMG-CoA) reductase is an enzyme that plays a crucial role in the synthesis of cholesterol in the body. It is found in the endoplasmic reticulum of cells and catalyzes the conversion of HMG-CoA to mevalonic acid, which is a key rate-limiting step in the cholesterol biosynthetic pathway.

The reaction catalyzed by HMG-CoA reductase is as follows:

HMG-CoA + 2 NADPH + 2 H+ → mevalonic acid + CoA + 2 NADP+

This enzyme is the target of statin drugs, which are commonly prescribed to lower cholesterol levels in the treatment of cardiovascular diseases. Statins work by inhibiting HMG-CoA reductase, thereby reducing the production of cholesterol in the body.

Hepatocytes are the predominant type of cells in the liver, accounting for about 80% of its cytoplasmic mass. They play a key role in protein synthesis, protein storage, transformation of carbohydrates, synthesis of cholesterol, bile salts and phospholipids, detoxification, modification, and excretion of exogenous and endogenous substances, initiation of formation and secretion of bile, and enzyme production. Hepatocytes are essential for the maintenance of homeostasis in the body.

Tritium is not a medical term, but it is a term used in the field of nuclear physics and chemistry. Tritium (symbol: T or 3H) is a radioactive isotope of hydrogen with two neutrons and one proton in its nucleus. It is also known as heavy hydrogen or superheavy hydrogen.

Tritium has a half-life of about 12.3 years, which means that it decays by emitting a low-energy beta particle (an electron) to become helium-3. Due to its radioactive nature and relatively short half-life, tritium is used in various applications, including nuclear weapons, fusion reactors, luminous paints, and medical research.

In the context of medicine, tritium may be used as a radioactive tracer in some scientific studies or medical research, but it is not a term commonly used to describe a medical condition or treatment.

High-performance liquid chromatography (HPLC) is a type of chromatography that separates and analyzes compounds based on their interactions with a stationary phase and a mobile phase under high pressure. The mobile phase, which can be a gas or liquid, carries the sample mixture through a column containing the stationary phase.

In HPLC, the mobile phase is a liquid, and it is pumped through the column at high pressures (up to several hundred atmospheres) to achieve faster separation times and better resolution than other types of liquid chromatography. The stationary phase can be a solid or a liquid supported on a solid, and it interacts differently with each component in the sample mixture, causing them to separate as they travel through the column.

HPLC is widely used in analytical chemistry, pharmaceuticals, biotechnology, and other fields to separate, identify, and quantify compounds present in complex mixtures. It can be used to analyze a wide range of substances, including drugs, hormones, vitamins, pigments, flavors, and pollutants. HPLC is also used in the preparation of pure samples for further study or use.

Lipids are a broad group of organic compounds that are insoluble in water but soluble in nonpolar organic solvents. They include fats, waxes, sterols, fat-soluble vitamins (such as vitamins A, D, E, and K), monoglycerides, diglycerides, triglycerides, and phospholipids. Lipids serve many important functions in the body, including energy storage, acting as structural components of cell membranes, and serving as signaling molecules. High levels of certain lipids, particularly cholesterol and triglycerides, in the blood are associated with an increased risk of cardiovascular disease.

Isotope labeling is a scientific technique used in the field of medicine, particularly in molecular biology, chemistry, and pharmacology. It involves replacing one or more atoms in a molecule with a radioactive or stable isotope of the same element. This modified molecule can then be traced and analyzed to study its structure, function, metabolism, or interaction with other molecules within biological systems.

Radioisotope labeling uses unstable radioactive isotopes that emit radiation, allowing for detection and quantification of the labeled molecule using various imaging techniques, such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). This approach is particularly useful in tracking the distribution and metabolism of drugs, hormones, or other biomolecules in living organisms.

Stable isotope labeling, on the other hand, employs non-radioactive isotopes that do not emit radiation. These isotopes have different atomic masses compared to their natural counterparts and can be detected using mass spectrometry. Stable isotope labeling is often used in metabolic studies, protein turnover analysis, or for identifying the origin of specific molecules within complex biological samples.

In summary, isotope labeling is a versatile tool in medical research that enables researchers to investigate various aspects of molecular behavior and interactions within biological systems.

Chenodeoxycholic acid and cholic acid are the two primary bile acids in humans. Chenodeoxycholic acid has two hydroxyl groups ... Chenodeoxycholic acid (CDCA; also known as chenodesoxycholic acid, chenocholic acid and 3α,7α-dihydroxy-5β-cholan-24-oic acid) ... Salts of this carboxylic acid are called chenodeoxycholates. Chenodeoxycholic acid is one of the main bile acids. It was first ... Some other mammals have muricholic acid or deoxycholic acid rather than chenodeoxycholic acid. It occurs as a white crystalline ...
... is a primary bile acid, synthesized in the liver and present in high concentrations in bile that is used therapeutically to ... Chenodeoxycholic acid (chenodiol) is a primary bile acid, synthesized in the liver and present in high concentrations in bile ... Chenodiol (Chenodeoxycholic Acid) No authors listed In: LiverTox: Clinical and Research Information on Drug-Induced Liver ... Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial ...
... is a primary bile acid, synthesized in the liver and present in high concentrations in bile that is used therapeutically to ... Chenodeoxycholic acid (chenodiol) is a primary bile acid, synthesized in the liver and present in high concentrations in bile ... Chenodiol (Chenodeoxycholic Acid) No authors listed In: LiverTox: Clinical and Research Information on Drug-Induced Liver ... Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial ...
Chenodeoxycholic acid and cholic acid are the two primary bile acids in humans. Chenodeoxycholic acid has two hydroxyl groups ... Chenodeoxycholic acid (CDCA; also known as chenodesoxycholic acid, chenocholic acid and 3α,7α-dihydroxy-5β-cholan-24-oic acid) ... Salts of this carboxylic acid are called chenodeoxycholates. Chenodeoxycholic acid is one of the main bile acids.[1][2][3] It ... Some other mammals have muricholic acid or deoxycholic acid rather than chenodeoxycholic acid.[1] It occurs as a white ...
One such compound is Chenodeoxycholic Acid, an extraordinary substance that has garnered attention for its versatile ... Chenodeoxycholic Acid: A Glimpse of the Extraordinary. Chenodeoxycholic Acid, abbreviated as CDCA, is a bile acid naturally ... As the symphony of health continues to play, let Chenodeoxycholic Acid Quote and MedicaPharmas visionary approach be your ... This resonant quote captures the essence of Chenodeoxycholic Acids impact. Lets explore how each element of the quote aligns ...
Chenodeoxycholic Acid (CDCA) *Ursodeoxycholic Acid (UDCA) ( Safe. Compatible. Minimal risk for breastfeeding and infant.) ... Chenodeoxycholic Acid (CDCA) (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.) ... Ursodeoxycholic Acid (UDCA) ( Safe. Compatible. Minimal risk for breastfeeding and infant.). Since each active ingredient of ... Ursodeoxycholic Acid (UDCA) There are no alternatives because it has very low risk level.. ...
We aimed to determine whether rectal distension and/or infusion of bile acids stimulates propagating or nonpropagating activity ... We concluded that rectal chenodeoxycholic acid in physiological concentrations is a potent stimulus for propagating pressure ... reduced after rectal chenodeoxycholic acid. The frequency of colonic propagating pressure wave sequences decreased ... but the frequency doubled after subsequent chenodeoxycholic acid infusion (P , 0.002). Nonpropagating activity decreased after ...
Combination of ursodeoxycholic acid and chenodeoxycholic acid for dissolution of cholesterol gallstones ... Combination of ursodeoxycholic acid and chenodeoxycholic acid for dissolution of cholesterol gallstones. In: Falk Workshop on ... Bile Acids in Hepatobiliary Disease; 29-30 Mar 1999, London, UK. (Falk Symposium) ISBN 9780792387558 ...
Could fecal bile acids have potential as biomarkers to predict CDI recurrence? ... This study investigated how gut microbiota-bile acid interactions relate to the pathogenesis of C. difficile infection. ... Chenodeoxycholic acid-3-sulfate (0.73). 64. 82. 53. 88. Note: Longitudinal-survival model was used to predict probability of ... Perturbations in bile acids (BAs) contribute to CDI pathogenesis and may be relevant to primary disease prognosis. ...
... cholesterol into bile acids in rat and human hepatocytes and by ... ... Bile acid synthesis, determined by conversion of [4-14C] ... Conversion of chenodeoxycholic acid to cholic acid by isolated ... Bile acid metabolism in mammals: IX. Conversion of chenodeoxycholic acid to cholic acid by isolated perfused rat liver. ... Rapid feedback inhibition of endogenous cholic and chenodeoxycholic acid synthesis by exogenous chenodeoxycholic acid in man. ...
... gallstones chenodeoxycholic acids (CDCA); Ursodeoxycholic acid (UDCA, ursodiol); Endoscopic retrograde cholangiopancreatography ...
Chenodiol is the non-proprietary name for chenodeoxycholic acid, a naturally occurring human bile acid. It is a bitter-tasting ... Bile acids, including Chenodiol and lithocholic acid, have no carcinogenic potential in animal models, but have been shown to ... deoxycholic acid, in an expanded bile acid pool. These actions contribute to biliary cholesterol desaturation and gradual ... Its chemical name is 3α, 7α-dihydroxy-5β-cholan-24-oic acid (C24H40O4), it has a molecular weight of 392.58, and its structure ...
... chenodeoxycholic and deoxycholic acids are more cytotoxic than cholic acid (3). The minimum 15-mL dose of sheep bile contains ... chenodeoxycholic, 23% cholic, and 5% lithocholic acids) -- the equivalent of 36% of the maximum daily dose of bile acids used ... Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. Ann Intern Med 1981; ... Bobowiec R. Effects of the intravenous infusion of sodium salts of bile acids on bile flow and bile acids of sheep {Polish}. ...
And its produced primarily by lactic acid bacteria. They also found bile acid differences with chenodeoxycholic acid reduced ... The microbiome also converts primary bile acids into secondary bile acids. And these bile acids have been shown to result in ... Hoel found bile acid and branched-chain amino acids and tryptophan metabolites as well. So, theres some things that do show ... And because we were talking about amino acids, I want to direct you to a really nice study that looked at 20 amino acids in the ...
... first-line therapy includes chenodeoxycholic acid (synthetic). Management also includes cholic acid and oral bile replacement. ... Xanthelasmas may be treated with topical trichloroacetic acid 50-100%, topical bichloracetic acid, excision, skin flap with ... Treatment of xanthelasma palpebrarum with bichloracetic acid. Dermatol Surg. 1998 Sep. 24(9):1027-31. [QxMD MEDLINE Link]. ... Haque MU, Ramesh V. Evaluation of three different strengths of trichloroacetic acid in xanthelasma palpebrarum. J Dermatolog ...
Cholic acid, another bile acid, has also been used to treat young children with CTX. Although chenodeoxycholic acid is ... Treatment with chenodeoxycholic acid normalizes the production of cholestanol. The efficacy of treatment with chenodeoxycholic ... The lack of this enzyme prevents cholesterol from being converted into a bile acid called chenodeoxycholic acid. Deposits of ... The lack of this enzyme prevents cholesterol from being converted into the bile acid chenodeoxycholic acid. The block in ...
Title: Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in ... The effects of TRO on the disposition of [(14)C]-labeled chenodeoxycholic acid ([(14)C]CDCA), an unconjugated cytotoxic BA, ... Chenodeoxycholic Acid/metabolism*; Chromans/toxicity*; Chromatography, High Pressure Liquid; Drug-Induced Liver Injury/etiology ... Typically, studies use taurocholic acid (TCA) as a model substrate to investigate effects of xenobiotics on BA disposition. ...
... chenodeoxycholic acid; DCA: deoxycholic acid; LCA: lithocholic acid; UDCA: ursodeoxycholic acid; muCA: muricholic acid; T-: ... The results were expressed as mean ± SD (n = 3-4 animals) CA: cholic acid; CDCA: ... histopathology scoremotilityDisease Activity Indexoxidative stressBA deconjugating bacteriaibdBA patterndaibiliary bile acids ...
fats (bile acids), specifically a bile acid called chenodeoxycholic acid.Mutations in the CYP27A1 gene lead to the ... abnormal ... down cholesterol to form a bile acid called chenodeoxycholic acid. The formation of bile acids from cholesterol is ... protein ... called cholesterol to form a bile acid called chenodeoxycholic acid. Bile acids are a component of a digestive ... ... It is treated with chenodeoxycholic acid (CDCA) replacement therapy. NIH: National Institute of Neurological ... ...
With an early accurate diagnosis, CTX can be effectively treated with chenodeoxycholic acid (CDCA) replacement therapy. CDCA ... In ARD, phytanic acid accumulates and is toxic to myelin.. *Infantile Refsum disease (IRD)-an inherited disorder that damages ... People with ARD lack the enzyme in peroxisomes that breaks down phytanic acid, a type of fat found in certain foods. ... the brain chemical N-acetyl-L-aspartate or N-acetyl-L-aspartic acid. ...
6-ethyl chenodeoxycholic acid; CDCA, 6-ethyl chenodeoxycholic acid; DMEM, Dulbeccos modified Eagles medium; FBS, fetal bovine ... Exposure of 3T3-L1 cells to INT-747 (6-ethyl cheno-deoxycholic acid), a potent and selective FXR ligand, increases preadipocyte ... In this study, we have investigated the role of the farnesoid X receptor (FXR), a bile acid-activated nuclear receptor, in ... fatty acid binding protein; SREBP-1c, sterol-regulatory element binding protein-1c; TNFα, tumor necrosis factor α; GW9662, 2- ...
It is a bile acid obtained from chenodeoxycholic acid by bacterial action. ChEBI CHEBI:16325. ... Lithocholic acid is a toxic secondary bile acid, causes intrahepatic cholestasis, has tumor-promoting activity. MedChem Express ... Lithocholic acid is a toxic secondary bile acid, causes intrahepatic cholestasis, has tumor-promoting activity.; Target: Others ... A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from ...
Chenodeoxycholic acid requires activation of EGFR, EPAC, and Ca2+ to stimulate CFTR-dependent Cl- secretion in human colonic ... The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of ... 8. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier ... Metabolism of lithocholic and chenodeoxycholic acids in the squirrel monkey.. Suzuki H; Hamada M; Kato F. Gastroenterology; ...
... and chenodeoxycholic acid were used as the positive agonist of PPAR, AhR, PXR, and FXR, respectively. *p , 0.05, **p , 0.01, ... 2019). Oleanolic acid and ursolic acid induce UGT1A1 expression in HepG2 cells by activating PXR rather than CAR. Front. ... 2014). Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of ... Rifampicin and chenodeoxycholic acid have been reported as a strong agonist of PXR and FXR, repectively, which were used as ...
... bile acids). Specifically, sterol 27-hydroxylase breaks down cholesterol to form a bile acid called chenodeoxycholic acid. The ... The most common mutation changes the amino acid arginine to the amino acid cysteine at position 362 in the protein (written as ... in amino acids typically disrupt the normal function of the protein and impair its ability to help form chenodeoxycholic acid. ... Norlin M, von Bahr S, Bjorkhem I, Wikvall K. On the substrate specificity of human CYP27A1: implications for bile acid and ...
... mitochondrial beta oxidation of unsaturated fatty acid, and bile acid metabolism. Pathways were validated using proteomics in ... mitochondrial beta oxidation of saturated fatty acids (l-octanoylcarnitine), bile acid biosynthesis (chenodeoxycholic acid ... including unsaturated fatty acid production/metabolism, mitochondrial beta oxidation of unsaturated fatty acid, and bile acid ... hippuric acid), porphyrin metabolism (bilirubin, chenodeoxycholate) and fatty acid elongation/degradation (palmitic acid) ( ...
If its diagnosed early, one type of leukodystrophy called CTX can be treated with chenodeoxycholic acid (CDCA) replacement ...
It is a synthetic derivative of natural bile acid chenodeoxycholic acid (CDCA), with potency 100 times more than CDCA. ... An omega-3 fatty acid rich diet promotes fatty acid oxidation and decreases fatty acid synthesis, thus improving the lipid ... Ghosh Laskar M, Eriksson M, Rudling M, Angelin B. Treatment with the natural FXR agonist chenodeoxycholic acid reduces ... The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. Clin ...
These findings suggest a defect in biliary excretion, particularly of chenodeoxycholic acid conjugates. ... Total serum bile acid concentrations are markedly elevated (i.e., usually ,200 mmol/L compared to normal concentrations of , 10 ... While the PFIC1 and PFIC2 involve a defect in bile acid secretion, PFIC3 involves a defect in phospholipid secretion. In PFIC3 ... The primary mechanism of disease in patients with PFIC1-2 is a defect in canalicular bile acid transport with primary retention ...

No FAQ available that match "chenodeoxycholic acid"

No images available that match "chenodeoxycholic acid"